NEXT-TFX, Inc. is developing compaction-resistant reverse osmosis membranes for ultra-high-pressure desalination and brine concentration.
Market Opportunity:
Seawater desalination, industrial brine concentration, direct lithium extraction, and zero liquid discharge (ZLD) applications represent multi-billion-dollar global markets. Conventional RO membranes fail under high-pressure/high-temperature conditions, limiting recovery rates and increasing operational costs. NEXT-TFX targets this $3B–4B addressable segment where conventional RO membranes encounter mechanical and economic limitations.
Technology:
Proprietary thin-film cross-linked (TFX™) RO membranes. TFX maintains structural stability, water permeability, and salt rejection at pressures up to 124 bar and temperatures to 85°C, unlike conventional polyamide membranes that experience flux decline. Membranes integrate into existing spiral-wound module configurations, enabling retrofit deployment without major plant redesign.
Advantages:
- Resists compaction under ultra-high-pressure
- Maintains performance at 85°C
- Compatible with existing infrastructure
- Reduces membrane replacement frequency
- Enables higher-recovery desalination
Development Stage:
- Pilot – Active pilot validation with ACWA (world’s largest private seawater desalination developer, Saudi Arabia). Progressing toward manufacturing scale-up.
IP Protection:
- Patent-pending thin-film cross-linking chemistry and thermoset composite membrane structure. IP differentiates NEXT-TFX through resistance to compaction under ultra-high-pressure conditions.
Select Press Releases/Publications/Presentations:
- Partnership announcements: ACWA Joint Development Agreement
- Ultrahigh pressure compaction-resistant thin film crosslinked composite reverse osmosis membranes Nature Communications (2025) https://doi.org/10.1038/s41467-025-63639-0
- Resilient high-temperature reverse osmosis desalination membranes (Heat Tolerance) Science Advances DOI: aea1505 (February 2026) https://www.science.org/journal/sciadv
Contact:
Website: www.next-tfx.com
Email: contact@next-tfx.com
Phone: 760-220-8798
LinkedIn: linkedin.com/company/next-membranes
- Anaco
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- Diatom Biolab
- Eximius Diagnostics
- Giant BioSystems
- Hikari Medical Technologies
- ImmunoVec
- MedStat AI Inc.
- Mervyn's Petcare, Inc.
- Meteor Biotech, LLC
- My Block Skin, Inc.
- Nanomega CryoAI
- NEXT-TFX, Inc.
- Paralos Bioscience Inc.
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Prosper DNA
- Protean Research, Inc.
- Purpose Bio
- RaizDx
- RiboForge
- Saku Biosciences, Inc.
- SolGrapH, Inc.
- Sorriso Pharmaceuticals
- Thermeutics, Inc.
- Vault Pharma
- Veergen, Inc.
- Yuyu Bio, Inc.